UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa

Clinical microbiology and infection, 2008-04, Vol.14 (4), p.330-336

2008

Volltextzugriff (PDF)

Lipid Formulations of Amphotericin B: Clinical Efficacy and Toxicities

Clinical infectious diseases, 1998-09, Vol.27 (3), p.603-618

1998

Volltextzugriff (PDF)

Antimicrobial Stewardship Opportunities in Patients with Bacteremia Not Identified by BioFire FilmArray

Journal of clinical microbiology, 2019-05, Vol.57 (5)

2019

Volltextzugriff (PDF)

Clinically significant bacteria/pyuria-the author responds

The American journal of emergency medicine, 2017-10, Vol.35 (10), p.1561-1561

2017

Volltextzugriff (PDF)

Emergency Department Urinary Antibiograms Differ by Specific Patient Group

Journal of clinical microbiology, 2017-09, Vol.55 (9), p.2629-2636

2017

Volltextzugriff (PDF)

A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients

Journal of antimicrobial chemotherapy, 2010-08, Vol.65 (8), p.1765-1770

2010

Volltextzugriff (PDF)

EPS7.4 Sub-inhibitory anti-staphylococcal antibiotics differentially modulate fibronectin binding protein-induced adhesion in Staphylococcus aureus isolates from adult cystic fibrosis patients

Journal of cystic fibrosis, 2017-06, Vol.16, p.S53-S53

2017

Volltextzugriff (PDF)

Molecular Correlation for the Treatment Outcomes in Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae with Reduced Susceptibility to Ceftazidime

Clinical infectious diseases, 2002-01, Vol.34 (2), p.135-146

2002

Volltextzugriff (PDF)

Therapeutic Challenges Associated with Extended-Spectrum, β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae

Pharmacotherapy, 2001-05, Vol.21 (5), p.583-592

Wong-Beringer, Annie

2001

Volltextzugriff (PDF)

WS7.2 Antibacterial activity of theta defensin (RTD-1) against clinical isolates of Pseudomonas aeruginosa

Journal of cystic fibrosis, 2014-06, Vol.13, p.S15-S15

2014

Volltextzugriff (PDF)

Use of an Efflux Pump Inhibitor To Determine the Prevalence of Efflux Pump-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2005-02, Vol.49 (2), p.565-570

2005

Volltextzugriff (PDF)

Implementing a program for switching from i.v. to oral antimicrobial therapy

American journal of health-system pharmacy, 2001-06, Vol.58 (12), p.1146-1149

2001

Volltextzugriff (PDF)

Leveraging Antimicrobial Stewardship in the Emergency Department to Improve the Quality of Urinary Tract Infection Management and Outcomes

Open forum infectious diseases, 2018-06, Vol.5 (6), p.ofy101-ofy101

2018

Volltextzugriff (PDF)

Systemic Antifungal Therapy: New Options, New Challenges

Pharmacotherapy, 2003-11, Vol.23 (11), p.1441-1462

2003

Volltextzugriff (PDF)

Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes

Journal of antimicrobial chemotherapy, 2005-04, Vol.55 (4), p.535-541

2005

Volltextzugriff (PDF)

Absolute Bioavailability and Pharmacokinetics of Linezolid in Hospitalized Patients Given Enteral Feedings

Antimicrobial Agents and Chemotherapy, 2005-09, Vol.49 (9), p.3676-3681

2005

Volltextzugriff (PDF)

Immune globulin therapy in allogeneic bone marrow transplant : a critical review

Bone marrow transplantation (Basingstoke), 1994-05, Vol.13 (5), p.499-510

1994

Volltextzugriff (PDF)

Safety and efficacy of Intralipid emulsions of amphotericin B

Journal of antimicrobial chemotherapy, 1996-09, Vol.38 (3), p.333-347

1996

Volltextzugriff (PDF)

Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome

Journal of antimicrobial chemotherapy, 2008-03, Vol.61 (3), p.714-720

2008

Volltextzugriff (PDF)

Suitability of caspofungin for aerosol delivery : Physicochemical profiling and nebulizer choice

Chest, 2005-11, Vol.128 (5), p.3711-3716

2005

Volltextzugriff (PDF)

Treating Serious Infections: Focus on Cefepime

Pharmacotherapy, 2004-12, Vol.24 (12P2), p.216S-223S

Wong-Beringer, Annie

2004

Volltextzugriff (PDF)

Caspofungin: A Potential Cause of Reversible Severe Thrombocytopenia

Pharmacotherapy, 2004-10, Vol.24 (10), p.1408-1411

2004

Volltextzugriff (PDF)

Pneumococcal Vaccination in Hospitalized Elderly Patients: Role of the Pharmacist

Pharmacotherapy, 2003-02, Vol.23 (2), p.199-208

2003

Volltextzugriff (PDF)

Nosocomial Funguria: Resultant Morbidity and Therapeutic Intervention

Clinical infectious diseases, 1993-12, Vol.17 (6), p.1066-1067

1993

Volltextzugriff (PDF)

Applying patient selection criteria for drotrecogin alfa therapy in practice

American journal of health-system pharmacy, 2003-07, Vol.60 (13), p.1345-1352

2003

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(106)
Berichte
(2)

Sprache

Englisch
(108)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Life Sciences & Biomedicine
(82)
Humans
(59)
Pharmacology & Pharmacy
(39)
Infectious Diseases
(38)
Microbiology
(38)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Male
(28)
Pharmacology. Drug Treatments
(26)
Aged
(25)
Female
(24)
Middle Aged
(24)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(23)
Microbial Sensitivity Tests
(20)
Adult
(18)
Mortality
(17)
Treatment Outcome
(16)
Anti-Bacterial Agents - Therapeutic Use
(15)
Antibiotics
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa

Lipid Formulations of Amphotericin B: Clinical Efficacy and Toxicities

Antimicrobial Stewardship Opportunities in Patients with Bacteremia Not Identified by BioFire FilmArray

Clinically significant bacteria/pyuria-the author responds

Emergency Department Urinary Antibiograms Differ by Specific Patient Group

A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients

EPS7.4 Sub-inhibitory anti-staphylococcal antibiotics differentially modulate fibronectin binding protein-induced adhesion in Staphylococcus aureus isolates from adult cystic fibrosis patients

Molecular Correlation for the Treatment Outcomes in Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae with Reduced Susceptibility to Ceftazidime

Therapeutic Challenges Associated with Extended-Spectrum, β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae

WS7.2 Antibacterial activity of theta defensin (RTD-1) against clinical isolates of Pseudomonas aeruginosa

Use of an Efflux Pump Inhibitor To Determine the Prevalence of Efflux Pump-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa

Implementing a program for switching from i.v. to oral antimicrobial therapy

Leveraging Antimicrobial Stewardship in the Emergency Department to Improve the Quality of Urinary Tract Infection Management and Outcomes

Systemic Antifungal Therapy: New Options, New Challenges

Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes

Absolute Bioavailability and Pharmacokinetics of Linezolid in Hospitalized Patients Given Enteral Feedings

Immune globulin therapy in allogeneic bone marrow transplant : a critical review

Safety and efficacy of Intralipid emulsions of amphotericin B

Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome

Suitability of caspofungin for aerosol delivery : Physicochemical profiling and nebulizer choice

Treating Serious Infections: Focus on Cefepime

Caspofungin: A Potential Cause of Reversible Severe Thrombocytopenia

Pneumococcal Vaccination in Hospitalized Elderly Patients: Role of the Pharmacist

Nosocomial Funguria: Resultant Morbidity and Therapeutic Intervention

Applying patient selection criteria for drotrecogin alfa therapy in practice

Suchergebnisse filtern